top of page

New York Office

News

Portfolio: Portfolio

May 9, 2022

SCG Cell Therapy Announces Clinical Trial Approval Of TCR-T Cell Therapy For Liver Cancer In Singapore

March 11, 2022

NMPA Clears IND For First T-Cell Receptor (TCR) T Cell Therapy To Treat Hepatitis B Virus (HBV) Associated Hepatocellular Carcinoma (HCC)

December 23, 2021

Lion TCR Receives FDA Fast Track Designation for its HBV-specific TCR T Cell Therapy for Hepatocellular Carcinoma.

September 23, 2021

Lion TCR Announces FDA Clearance of its IND Application for its Lead Investigational Product, LioCyx-M004, for Hepatocellular Carcinoma.

bottom of page